Counterforce Health Team

Counterforce Health Team

How to Get Ocrevus Covered by UnitedHealthcare in North Carolina: PA Forms, Appeals, and Approval Timeline

Answer Box: Getting Ocrevus Covered by UnitedHealthcare in North Carolina UnitedHealthcare covers Ocrevus (ocrelizumab) in North Carolina when prior authorization criteria are met: confirmed MS diagnosis (relapsing forms or primary progressive), documented treatment history, and clinical necessity. No universal step therapy requirement exists in UHC's national policy, but
6 min read

How to Get Soliris (Eculizumab) Covered by Blue Cross Blue Shield of Michigan: Complete Guide with Forms, Timelines, and Appeal Scripts

Answer Box: Getting Soliris Covered by BCBS Michigan To get Soliris (eculizumab) covered by Blue Cross Blue Shield of Michigan, you'll need prior authorization through their NovoLogix system. Since July 2024, BCBS Michigan requires patients to try Empaveli (pegcetacoplan) first for most indications unless contraindicated. The fastest path:
7 min read

How to Get iLink® Corneal Cross-Linking Covered by Cigna in Georgia: Complete Timeline, Forms & Appeals Guide

Answer Box: Getting iLink® Covered by Cigna in Georgia Cigna typically covers FDA-approved iLink® epithelium-off corneal cross-linking for progressive keratoconus when prior authorization criteria are met. Standard approval takes 5 business days; expedited review within 72 hours if vision-threatening. First step: Have your ophthalmologist document keratoconus progression (≥1.0 D
6 min read

How to Get Daybue (trofinetide) Covered by Blue Cross Blue Shield California: Forms, Appeals, and State Protections

Answer Box: Getting Daybue Covered in California Blue Shield of California requires prior authorization for Daybue (trofinetide) with specific clinical criteria: confirmed Rett syndrome with MECP2 mutation, age ≥2 years, and neurologist prescriber. Initial approval covers 3 months, renewals require evidence of clinical benefit. If denied, California's Independent
6 min read

How to Get Mavenclad (Cladribine Tablets) Covered by Humana in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad (Cladribine Tablets) Covered by Humana in Washington Eligibility: Adults with relapsing forms of multiple sclerosis (including active secondary progressive MS) who meet lymphocyte count requirements and have tried or cannot use preferred disease-modifying therapies. Fastest Path: Your neurologist submits a prior authorization through Humana's
7 min read